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Synthesis of Grazoprevir
Significance: Grazoprevir is an NS3/4a protease inhibitor. It was approved by the FDA in 2016 as a combination drug with elbasvir (Zepatier ® ) for the treatment of hepatitis C viral infections. The scheme depicts the chemistry developed to conjoin the fragments A, B, D, and H on large scale (>100 kg) in 51% overall yield and >99.8% purity.
Comment:
The thermal instability of the free base of alkyne D was a challenge in the Sonogashira reaction. By using methanol as solvent, catalyst stability and reactivity was improved as evinced by increased catalytic turnover at milder temperatures (35 °C). The free base of sulfonamide H was unstable at ambient temperature. Therefore, the EDC coupling was conducted at 0 °C by adding pyridine to a slurry of the acid G and the PTSA salt H in THF. 
